Zhongshan Hospital of Traditional Chinese Medicine
Welcome,         Profile    Billing    Logout  
 8 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhang, Fan
ESPTTN, NCT06423235: Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules

Not yet recruiting
4
426
RoW
regular dose of JiRui® Prunella oral liquid, 2x regular dose of JiRui® Prunella oral liquid, regular dose of placebo, 2x regular dose of placebo
Xintian Pharmaceutical
Thyroid Nodule
07/25
07/28
NCT05812014: Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older

Recruiting
3
9800
RoW
SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution
AIM Vaccine Co., Ltd., LiveRNA Therapeutics Inc., Ningbo Rongan Biological Pharmaceutical Co. Ltd.
SARS-CoV-2
03/24
06/24
RECAST-MT, NCT06559241: Remote Ischemic Conditioning for Acute Ischemic Stroke Treated with Mechanical Thrombectomy（）

Recruiting
3
2105
RoW
14-day remote ischemic conditioning, 14-day RIC, 30-day remote ischemic conditioning, 30-day RIC, Endovascular thrombectomy, EVT, Best medical management
Capital Medical University
Acute Ischemic Stroke, Anterior Circulation Brain Infarction
11/26
02/27
INSPIRE-BDLL, NCT06649721: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

Not yet recruiting
3
120
RoW
bedaquiline, BDQ, B, delamanid, DLM, D, linezolid, LZD, L, Levofloxacin, LFX, Clofazimine, CFZ, C
Huashan Hospital, Beijing Chest Hospital
Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis
06/27
06/27
INSPIRE-CODA, NCT06081361: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

Recruiting
3
186
RoW
Bedaquiline, BDQ, Delamanid, DLM, Contezolid, CZD, Levofloxacin, LFX, Moxifloxacin, MFX, Clofazimine, CFZ, Linezolid, LZD, Cycloserine, CS, Prothionamide, Pto, Pyrazinamide, PZA, Para-Aminosalicylic Acid, PAS, Ethambutol, EMB
Beijing Chest Hospital, National Medical Center for Infectious Diseases
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
10/26
12/26
NCT02029937: High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

Recruiting
2
1300
US, RoW
Proflavine, high resolution imaging, Proflavine hemisulfate
Anandasabapathy, Sharmila, M.D., William Marsh Rice University, Baylor College of Medicine
Suspected or Known Squamous Cell Neoplasia, Prior History of Squamous Cell Dysplasia and /or Neoplasia
12/21
12/21
NCT05939648: A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

Active, not recruiting
2
450
RoW
SARS-CoV-2 Bivalent mRNA Vaccine, LVRNA021, Saline
AIM Vaccine Co., Ltd., Ningbo Rongan Biological Pharmaceutical Co., Ltd.
SARS-CoV-2
11/23
12/24
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis

Suspended
2
279
Europe, US, RoW
zetomipzomib, KZR-616, placebo, matching placebo
Kezar Life Sciences, Inc.
Lupus Nephritis
05/26
07/26
NCT05939596: A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

Active, not recruiting
1
60
RoW
SARS-CoV-2 Bivalent mRNA Vaccine, LVRNA021, Saline
AIM Vaccine Co., Ltd., First Affiliated Hospital Bengbu Medical College
SARS-CoV-2
09/23
08/24
NCT06773286: Combining Spinal Cord Transcutaneous Stimulation and Activity-based Training in Inpatient Rehabilitation to Facilitate Upper Limb Function of Individuals with Acute to Subacute Cervical Spinal Cord Injury

Recruiting
N/A
30
US
Active Stimulation, Sham, Training only
Kessler Foundation
Spinal Cord Injury Cervical
12/25
12/25
NCT05845372: Association of Prophylactic Use of Stress Ulcer Drugs and Clinical Outcomes in Patients With Acute Anterior Circulation Thrombectomy

Not yet recruiting
N/A
2592
RoW
Nanfang Hospital of Southern Medical University, The Fourth Affiliated Hospital of Guangzhou Medical University, The Affiliated Hospital of Inner Mongolia Medical University, Second Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital of Guangxi Medical University, Fujian Medical University Union Hospital, Huizhou Municipal Central Hospital, Haikou People's Hospital, Kashgar 1st People's Hospital, Ganzhou City People's Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Huadu District People's Hospital of Guangzhou, Dongguan donghua hospital, Sinopharm North Hospital, Heyuan people's Hospital, Hainan People's Hospital, Hainan Traditional Chinese Medicine Hospital, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, The Second Hospital University of South China, Dongguan People's Hospital, Yueyang People's Hospital
Acute Ischemic Stroke
01/27
01/27
NCT05914272: Association of Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric Infarction

Not yet recruiting
N/A
2592
RoW
Osmotic drugs
Nanfang Hospital of Southern Medical University, The Second Hospital University of South China, The Affiliated Hospital of Inner Mongolia Medical University, Second Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital of Guangxi Medical University, Fujian Medical University Union Hospital, Huizhou Municipal Central Hospital, Haikou People's Hospital, Kashgar 1st People's Hospital, Ganzhou City People's Hospital, The Fourth Affiliated Hospital of Guangzhou Medical University, Dongguan People's Hospital, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Hainan Traditional Chinese Medicine Hospital, Hainan People's Hospital, Sinopharm North Hospital, Huadu District People's Hospital of Guangzhou, Guangdong Provincial Hospital of Traditional Chinese Medicine
Stroke
01/27
01/27
Maid, Pablo Jorge
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis

Suspended
2
279
Europe, US, RoW
zetomipzomib, KZR-616, placebo, matching placebo
Kezar Life Sciences, Inc.
Lupus Nephritis
05/26
07/26

Download Options